Use of C-reactive protein for prediction of sinus rhythm maintenance after pharmacologic cardioversion in patients with Metabolic Syndrome

• Main Authors: Jani Ylber (Author), Neziri Entela (Author), Paparisto Sokol (Author), Bara Petrit (Author), Haxhirexha Kastriot (Author), Pocesta Bekim (Author), Rexhepi Atila (Author), Xhunga Sotiraq (Author), Serani Artur (Author), Ferati Fatmir (Author), Zeqiri Agim (Author), Kamberi Ahmet (Author)
• Format: Book
• Published: Sciendo, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Approximately 50% of patients undergoing cardioversion present with a recurrence of Atrial Fibrillation ( AF) within 3-6 months of cardioversion despite ongoing antiarrhythmic treatment (AAD). Inflammation has been involved in the pathogenesis of both metabolic syndrome (MS) and atrial fibrillation....